根管治疗改善根尖周炎相关全身炎症并恢复血脑屏障完整性
本研究纳入27例根尖周炎患者和27例健康对照,评估根尖周炎与循环炎症因子及细胞屏障通透性相关血清蛋白的关联,并探讨根管治疗对体外内皮屏障完整性的影响。结果显示根尖周炎患者基线ZO-1和Claudin-5血清水平显著升高,根管治疗后6和12个月逐渐下降,且治疗后血清可恢复体外血脑屏障模型中ZO-1表达。
要点
- 根尖周炎患者血清ZO-1和Claudin-5水平显著高于健康对照。
- 根管治疗后6和12个月血清ZO-1和Claudin-5水平逐渐下降。
- 治疗后血清可恢复体外血脑屏障模型中ZO-1表达。
核心结论
- 根尖周炎患者的全身炎症与内皮屏障功能紊乱相关,成功的根管治疗与炎症因子水平降低及屏障完整性关键蛋白的恢复相关。
研究设计与样本
- 纳入27例根尖周炎患者和27例健康对照,患者接受根管治疗并在治疗后6和12个月随访。
- 采用ELISA检测血清ZO-1、Claudin-5和VE-cadherin水平,并使用hCMEC/D3细胞体外微血管内皮血脑屏障模型评估患者血清对屏障功能和细胞通透性的影响。
主要发现
- 基线时根尖周炎患者血清ZO-1和Claudin-5水平显著高于对照(p < 0.001),VE-cadherin组间无显著差异。
- 根管治疗后6和12个月血清ZO-1和Claudin-5水平逐渐下降。
- 调整BMI和吸烟状态后,基线ZO-1和Claudin-5的组间差异仍显著。
- 基线时根尖周炎组ZO-1和Claudin-5水平与IL-1β和IL-6呈中度相关。
- 体外实验中基线根尖周炎血清增加内皮通透性,治疗后血清不损害屏障完整性,且治疗后血清(t6和t12)使ZO-1表达恢复至对照水平。
临床怎么用
- 根尖周炎患者应关注全身炎症状态及内皮屏障功能,根管治疗可能有助于改善这些指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: A growing body of research supports an association between periapical inflammation and an increased risk of various systemic effects. However, there is currently no scientific evidence demonstrating a causal relationship between this inflammation and changes in epithelial or endothelial permeability in patients with apical periodontitis (AP). This study aimed to evaluate the potential association between AP, circulating inflammatory cytokines known to affect cellular permeability, and serum proteins associated with an impaired cellular barrier permeability. Additionally, we investigated the effect of endodontic treatment on in vitro endothelial barrier integrity. METHODOLOGY: A total of 27 patients with AP and 27 healthy control subjects were enrolled. AP patients underwent root canal treatment and were followed up at 6 and 12 months post-treatment. Serum levels of human ZO-1, Claudin-5, and VE-cadherin were measured using enzyme-linked immunosorbent assays (ELISA). An in vitro model of the microvascular endothelial blood-brain barrier (hCMEC/D3 cells) was used to assess the biological activity of patient sera on barrier function and cellular permeability. RESULTS: At baseline, patients with AP showed significantly higher serum levels of ZO-1 and Claudin-5 compared with controls (p < 0.001), whereas VE-cadherin levels did not differ significantly between groups. Serum ZO-1 and Claudin-5 levels progressively decreased at 6 and 12 months following root canal treatment. In adjusted analyses, the baseline between-group differences for ZO-1 and Claudin-5 remained significant after adjustment for BMI and smoking status. ZO-1 and Claudin-5 levels showed moderate correlations with IL-1β and IL-6 in the AP group at baseline. In vitro, exposure to baseline AP sera increased endothelial permeability, indicating barrier disruption, while sera collected after treatment did not impair barrier integrity. Moreover, cellular ZO-1 expression remained stable in cells treated with control sera but was markedly reduced after exposure to sera from untreated AP patients (t0), whereas post-treatment sera (t6 and t12) restored ZO-1 expression to control levels. CONCLUSIONS: Systemic inflammation in patients with apical periodontitis to deranged endothelial barrier function. Successful endodontic treatment was associated with reduced levels of inflammatory cytokines and the restoration of serum and cellular proteins essential for barrier integrity.
引用
- Bergandi L, Alovisi M, Tachis E, et al. Endodontic Treatment of Apical Periodontitis Mitigates Systemic Inflammation and Restores the Blood-Brain Barrier Integrity in an In Vitro Model. Int Endod J. 2026. PMID: 42388081. doi:10.1111/iej.70216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。